WANY
ACAD icon

Wealthspire Advisors (New York)’s Acadia Pharmaceuticals ACAD Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,640
Closed -$156K – 53
2018
Q4 		$156K Buy
+9,640
New +$156K 0.02% 79